Evidence map›Paper›PMID 36302862›Full record

ArticleScientific reports2022

Revisiting the COVID-19 fatality rate and altitude association through a comprehensive analysis.

Carson Bridgman, Jacob Gerken, Joshua Vincent, Amanda E Brooks, Isain Zapata

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Altitude and case fatality rate from COVID-19 during the pandemic in Peru, 2020-2022.Revista peruana de medicina experimental y salud publica · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carson BridgmanDepartment of Biomedical Sciences, Rocky Vista University, College of Osteopathic Medicine, 8401 S. Chambers Rd., Parker, CO, 80134, USA.
Jacob GerkenDepartment of Biomedical Sciences, Rocky Vista University, College of Osteopathic Medicine, 8401 S. Chambers Rd., Parker, CO, 80134, USA.
Joshua VincentDepartment of Biomedical Sciences, Rocky Vista University, College of Osteopathic Medicine, 8401 S. Chambers Rd., Parker, CO, 80134, USA.
Amanda E BrooksDepartment of Research and Scholarly Activity, Rocky Vista University, College of Osteopathic Medicine, Ivins, UT, 84738, USA.
Isain ZapataDepartment of Biomedical Sciences, Rocky Vista University, College of Osteopathic Medicine, 8401 S. Chambers Rd., Parker, CO, 80134, USA. izapata@rvu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of COVID-19 virus has led to a pandemic with staggering morbidity and mortality. There is evidence showing that pre-existing conditions and environmental factors are associated with worse COVID-19 outcomes. Among these conditions, altitude is of particular interest. Altitude has been shown to influence the morbidity and mortality of multiple chronic pathologies such as cardiovascular disease, chronic obstructive pulmonary disease and lung cancer. COVID-19 fatality rate has been associated with as altitude as well, but findings are disputed. Therefore, we revisit this assessment with a comprehensive analysis of the relationship between COVID-19 fatality rates and altitude for the Mountain region of the United States while considering the effect of additional comorbidities and sociodemographic factors. A Generalized Additive Model (GAM) approach using one year of county data adjusted by population density was performed to evaluate associations within states and for the whole region. Our analysis revealed a consistent effect where COVID-19 case-fatality rate is decreased with higher altitude, even when controlling for pre-existing conditions and certain demographic variables. In summary, the work presented provides evidence that suggests that the protective effects of high altitude are likely to be influenced by physiologic factors but demographic trends that are associated with life at high altitude must also be considered.

Indexed as

COVID-19AltitudeHumansMorbidityPandemicsSARS-CoV-2United States

Identifiers

PMID36302862
PMCPMC9610325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.